Global Surgical Instruments Market Size, Share, Opportunities, COVID-19 Impact, And Trends By Surgery Type (Open Surgery, Minimally Invasive Surgery, Robotic Surgery, Non-Robotic (Endoscopic) Surgery), By Product (Surgical Sutures And Staples, Hand-held Surgical Devices, Electrosurgical Devices, Other Surgical Devices), By Surgical Procedure (Cataract Surgery, Heart Surgery, Caesarean Section, Low Back Pain Surgery, Others), By End User (Hospital, Ambulatory Surgical Center, Specialized Clinic, Life Sciences And Biomedical Research Organization), And By Geography- Forecasts From 2022 To 2027

  • Published : Aug 2022
  • Report Code : KSI061613459
  • Pages : 120

The global surgical instruments market is projected to grow at a CAGR of 6.79% to reach US$80.780 billion by 2027, from US$51.018 billion in 2020.

The global surgical instruments market is projected to surge at a significant growth rate in the forecast period owing to the high prevalence of cardiovascular diseases in the world. These include coronary heart diseases, and rheumatic heart diseases, among other cardiac diseases, driving the market demand in the forecast period. The growing global geriatric population is further propagating the market demand with the surge in age-associated diseases requiring surgeries for treatment, further promoting the improvement in the quality of patients' lives.

The growing adoption of minimally invasive surgeries is considered to be one of the major drivers where surgical instruments in various robotic and non-robotic surgeries are fueling the market demand, leading to the sales of surgical instruments.

 The rise in minimally invasive procedures will provide a sustainable opportunity for the market to grow where these procedures help patients recover fast with a small incision in comparison to a normal surgery with a comparatively faster healing time. After the procedure is over, a patient's hospital stay is reduced with minimum scars left. Blood loss during surgery is also prevented, along with the reduction of post-surgical complications, and the patient is free to perform his or her daily routine activities within a few weeks. Furthermore, the growing number of road accidents is resulting in a surge of emergency cases, thus contributing to the growth of the global surgical instruments market in the forecast period.

On the basis of geography, North America is estimated to hold a significant market share with the highest health expenditure in the United States and state-of-the-art healthcare facilities. On the other hand, the Asia Pacific region is accounted to be among the fastest-growing regions due to the high prevalence of several chronic diseases in the region that demands surgery. 

The increasing adoption of advanced surgical procedures is driving market growth in the forecast period.

Advanced surgical treatments, including the adoption of minimally invasive surgeries, are transforming healthcare with the provision of extraordinary care and reduced surgery time, providing benefits to a wider population of patients worldwide. In addition, it has also helped patients to live longer and improve their quality of life. Technological advancements help to solve critical health issues by allowing physicians to treat their patients in a more efficient manner as compared to traditional ones. With the onset of minimally invasive surgeries, patients experience fewer scars, reducing their recovery time as well.

Several advanced surgical treatments have helped survivors survive major heart attacks. For example, angioplasty is usually performed in the case of the thickening of arterial walls due to the formation of plaque in them. This procedure requires the opening of the stiff arteries using catheters, balloon catheters, and stents. The procedures are known as percutaneous coronary intervention (PCI), balloon angioplasty, and coronary artery balloon dilation. Laser Angioplasty is another technique similar to the above-explained angioplasty. The only difference is that the catheter contains a laser tip that opens up the blocked artery and the pulsating beam of the laser vaporizes the plaque build-up.

Other examples include artificial heart valve surgery, also known as heart valve replacement surgery, which helps in the replacement of a faulty heart valve with that of a normal healthy one, thus restoring the function of the heart valves. Atherectomy helps in the cutting-off of the plaques via a catheter having a rotating shaver.

The minimally invasive coronary artery bypass graft surgery makes use of small incisions in the chest or leg to treat blocked arteries and restore normal blood supply to the heart. The patient is relieved from the hospital faster compared to the traditional open-heart surgery patient. For a patient suffering from a condition known as supraventricular tachyarrhythmias, also known as rapid heartbeats or arrhythmias. A procedure known as radiofrequency ablation helps in the treatment of these arrhythmias where a catheter with an electrode at its tip is guided to that side of the heart muscle that stimulates an abnormal heart rhythm. Hence, a mild and painless radiofrequency energy transmitting heat destroys the selected heart muscle carefully in a very small area.

To relieve highly sick patients because of severe chest pain known as angina, a procedure known as Trans myocardial Revascularization (TMR) is performed, which makes use of a laser beam to enter the pumping chamber through the left side of the chest. However, sometimes this procedure is done in combination with bypass surgery if needed. Several other procedures involve pacemaker surgery and minimally invasive surgeries for the treatment of congenital heart diseases, which have proven to be a lifesaver for many patients. Post-procedure, the patients can lead their lives peacefully with few or no complications at all. Hence, this is known to have a high impact on the growth of the global surgical instruments market in the forecast period.

Concerns regarding the risks related to device-associated infections are restraining the market's growth in the forecast period.

Catheter-associated infections are rare but are hard to treat and potentially devastating. Septic complications have been found to be associated with several angioplasty procedures. There have been cases where life-threatening complications have been found after cardiac catheterization alone or after subsequent coronary angioplasty procedures. In order to maintain a balance between the functional ability of the implanted device and improved quality of life, one needs to be cautious regarding the spreading of infections caused by the implants. Concerns are more critical for patients who have a weak immune system or whose immunity becomes weak due to medical reasons and who have to undergo multiple surgeries due to a large number of complications due to device-related infections. Every year patients undergo operations that include the implantation of venous catheters, embolism protection devices, left ventricular assist devices, and various other permanent or temporary implants. These procedures lead to infections, which include surgical-site infections, having a low-to-medium impact on hampering the market growth in the forecast period and the upcoming years.

Key Developments in the Market:

  • In May 2022, Surgical Holdings, a renowned surgical instruments manufacturer, launched a green initiative across its firm to minimize its carbon footprint. As part of this initiative, the firm introduced a unique Ethical Duty Smart Repair Service to actively promote the refurbishment and repair of surgical devices and instruments to reduce global steel wastage. Through the firm's initiative, consumers can now access the services remotely on its website dashboard, Surgifix.
  • In September 2021, Bolder Surgical Holdings launched the CoolSeal Vessel Sealing platform globally. The platform's suite comprises 3mm Mini and 5mm Trinity Divider/Sealer/Dissector. Its product portfolio is developed to offer surgeons a selection of versatile and innovative options to reduce the surgical impact on patients. Furthermore, owing to the approval of new international regulatory approvals, its medical device offerings are available across 20 countries across the globe.
  • In January 2020, Symmetry Surgical, Inc. completed the acquisition of The O.R. company, a manufacturer of innovative and high-quality surgical devices. The acquisition strengthens Symmetry's current instrumentation portfolio and broadens its selection of minimally invasive surgical instruments by introducing products with high levels of clinical acceptance and competitive pricing.

COVID-19 Impact on Surgical Instruments Market

COVID-19 had a significant impact on the global surgical instrument market. The introduction of several regulations and limitations to halt the rapid spread of the virus amid the pandemic had caused the number of surgeries across the globe to be significantly impacted. Several elective surgeries were delayed due to such regulations. According to the Australian Institute of Health and Welfare, the introduced restrictions posed by the pandemic had negatively impacted the admissions to hospitals between 2018-19 and 2019-20 by 1.7% in public hospitals and 4.5% in private hospitals.

Global Surgical Instruments Market Scope:


Report Metric Details
 Market Size Value in 2020  US$51.018 billion
 Market Size Value in 2027  US$80.780 billion
 Growth Rate  CAGR of 6.79% from 2020 to 2027
 Base Year  2020
 Forecast Period  2022–2027
 Forecast Unit (Value)  USD Billion
 Segments Covered  Surgery Type, Product, Surgical Procedure, End User, And Geography
 Regions Covered  North America, South America, Europe, Middle East and Africa, Asia Pacific
 Companies Covered GPC Medical Ltd., Inami & Co.,Ltd, Medtronic, Ethicon (Johnson & Johnson Family of Companies), B. Braun Melsungen AG, Stryker, Smith+Nephew, Microline Surgical, CONMED Corporation, Zimmer Biomet
 Customization Scope  Free report customization with purchase



  • By Surgery Type
    • Open Surgery
    • Minimally Invasive Surgery
    • Robotic Surgery
    • Non-Robotic (Endoscopic) Surgery
  • By Product
    • Surgical sutures and staples
    • Hand-held surgical devices
    • Electrosurgical devices
    • Other Surgical Devices
  • By Surgical Procedure
    • Cataract Surgery
    • Heart Surgery
    • Caesarean Section
    • Low Back Pain Surgery
    • Others
  • By End User
    • Hospital
    • Ambulatory Surgical Center
    • Specialized Clinic
    • Life Sciences and Biomedical Research Organization
  • By Geography
    • North America
      • USA
      • Canada
      • Mexico
    • South America
      • Brazil
      • Argentina
      • Others
    • Europe
      • UK
      • Germany
      • France
      • Spain
      • Italy
      • Others
    • Middle East and Africa
      • UAE
      • Israel
      • Saudi Arabia
      • Others
    • Asia Pacific
      • Japan
      • China
      • India
      • Australia
      • Indonesia
      • Thailand
      • Others

Frequently Asked Questions (FAQs)

The global surgical instruments market is projected to reach a market size of US$80.780 billion in 2027.
Surgical Instruments Market was valued at US$51.018 billion in 2020.
The surgical instruments market is projected to grow at a CAGR of 6.79% over the forecast period.
North America is estimated to hold a significant share of the surgical instruments market with the highest health expenditure in the United States and state-of-the-art healthcare facilities.
The global surgical instruments market is projected to surge at a significant growth rate in the forecast period owing to the high prevalence of cardiovascular diseases in the world.
1.1. Market Overview
1.2. COVID-19 Scenario
1.3. Market Definition
1.4. Market Segmentation

2.1. Research Data
2.2. Assumptions

3.1. Research Highlights

4.1. Market Drivers
4.2. Market Restraints
4.3. Porter's Five Force Analysis
4.3.1. Bargaining Power of Suppliers
4.3.2. Bargaining Power of Buyers
4.3.3. Threat of New Entrants
4.3.4. Threat of Substitutes
4.3.5. Competitive Rivalry in the Industry
4.4. Industry Value Chain Analysis

5.1. Introduction
5.2. Open Surgery
5.3. Minimally Invasive Surgery
5.3.1. Robotic Surgery
5.3.2. Non-Robotic (Endoscopic) Surgery

6.1. Introduction
6.2. Surgical sutures and staples
6.3. Hand-held surgical devices 
6.4. Electrosurgical devices 
6.5. Other Surgical Devices

7.1. Introduction
7.2. Cataract Surgery
7.3. Heart Surgery
7.4. Caesarean Section
7.5. Low Back Pain Surgery
7.6. Others

8.1. Introduction
8.2. Hospital
8.3. Ambulatory Surgical Center
8.4. Specialized Clinic
8.5. Life Sciences and Biomedical Research Organization

9.1. Introduction
9.2. North America
9.2.1. United States
9.2.2. Canada
9.2.3. Mexico
9.3. South America
9.3.1. Brazil
9.3.2. Argentina
9.3.3. Others
9.4. Europe
9.4.1. UK
9.4.2. Germany
9.4.3. France
9.4.4. Spain
9.4.5. Italy
9.4.6. Others
9.5. Middle East and Africa
9.5.1. United Arab Emirates
9.5.2. Israel
9.5.3. Saudi Arabia
9.5.4. Others
9.6. Asia Pacific
9.6.1. Japan
9.6.2. China
9.6.3. India
9.6.4. Australia
9.6.5. Indonesia
9.6.6. Thailand
9.6.7. Others

10.1. Major Players and Strategy Analysis
10.2. Emerging Players and Market Lucrativeness
10.3. Mergers, Acquisitions, Agreements, and Collaborations
10.4. Vendor Competitiveness Matrix

11.1. GPC Medical Ltd.
11.2. Inami & Co.,Ltd
11.3. Medtronic
11.4. Ethicon (Johnson & Johnson Family of Companies)
11.5. B. Braun Melsungen AG
11.6. Stryker
11.7. Smith+Nephew
11.8. Microline Surgical
11.9. CONMED Corporation
11.10. Zimmer Biomet

GPC Medical Ltd.

Inami & Co.,Ltd


Ethicon (Johnson & Johnson Family of Companies)

B. Braun Melsungen AG



Microline Surgical

CONMED Corporation

Zimmer Biomet